Patrizia Perri Selected Research

Patrizia Perri Research Topics

Disease

28	Neoplasms (Cancer) 02/2024 - 07/2007
18	Neuroblastoma 01/2023 - 07/2007
4	Lung Neoplasms (Lung Cancer) 02/2022 - 12/2011
4	Neoplasm Metastasis (Metastasis) 05/2021 - 10/2013
3	Carcinogenesis 03/2022 - 10/2015
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2021 - 11/2014
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2017 - 01/2016
2	Fibrosis (Cirrhosis) 01/2017 - 01/2016
2	Necrosis 10/2013 - 09/2013
1	Melanoma (Melanoma, Malignant) 08/2021
1	Liver Diseases (Liver Disease) 01/2016
1	Cicatrix (Scar) 01/2016
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 11/2014
1	Thymoma (Thymic Carcinoma) 10/2013
1	Uveal melanoma 10/2013

Drug/Important Bio-Agent (IBA)

8	Liposomes (Liposome)IBA 08/2021 - 07/2010
8	Peptides (Polypeptides)IBA 06/2021 - 07/2010
6	MicroRNAs (MicroRNA)IBA 02/2022 - 01/2019
5	Anaplastic Lymphoma KinaseIBA 10/2015 - 10/2008
4	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2021 - 07/2010
4	CD13 Antigens (Alanine Aminopeptidase)IBA 08/2015 - 07/2010
3	Lipid NanoparticlesIBA 02/2022 - 01/2019
3	LigandsIBA 11/2015 - 07/2010
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2013 - 07/2007
2	Topotecan (Hycamtin)FDA LinkGeneric 01/2023 - 06/2021
2	NucleolinIBA 11/2022 - 06/2021
2	RetinoidsIBA 08/2021 - 09/2013
2	FenretinideIBA 08/2021 - 09/2013
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 11/2015
2	AntibodiesIBA 10/2013 - 09/2013
2	Phosphotransferases (Kinase)IBA 10/2013 - 10/2008
2	Matrix Metalloproteinases (MMPs)IBA 09/2013 - 12/2011
2	Glutamyl Aminopeptidase (Aspartyl Aminopeptidase)IBA 01/2013 - 07/2010
2	Small Interfering RNA (siRNA)IBA 12/2011 - 06/2011
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2011 - 06/2011
1	Tetrazolium SaltsIBA 01/2023
1	Immunoconjugates (Immunoconjugate)IBA 01/2023
1	DuocarmycinsIBA 01/2023
1	Temozolomide (Temodar)FDA LinkGeneric 01/2023
1	RNA (Ribonucleic Acid)IBA 03/2022
1	Transcription Factors (Transcription Factor)IBA 11/2021
1	Nanoparticle Drug Delivery SystemIBA 08/2021
1	Peptide TIBA 06/2021
1	Proteins (Proteins, Gene)FDA Link 06/2021
1	Surface Antigens (Surface Antigen)IBA 05/2021
1	LuciferasesIBA 06/2020
1	Antineoplastic Agents (Antineoplastics)IBA 01/2019
1	Evans Blue (Blue, Evans)FDA Link 11/2018
1	Neuropilin-1IBA 11/2018
1	Coloring Agents (Dyes)IBA 11/2018
1	3-deazaneplanocinIBA 01/2017
1	Histones (Histone)IBA 01/2017
1	Histone MethyltransferasesIBA 01/2017
1	LipidsIBA 01/2016
1	Immunoglobulin FragmentsIBA 01/2016
1	SuspensionsIBA 11/2015
1	CrizotinibIBA 10/2015
1	ensartinibIBA 10/2015
1	Tyrosine Kinase InhibitorsIBA 10/2015
1	Bortezomib (Velcade)FDA Link 08/2015
1	Protein Isoforms (Isoforms)IBA 04/2015
1	Bevacizumab (Avastin)FDA Link 11/2014
1	ErbB Receptors (EGF Receptor)IBA 10/2013
1	Epidermal Growth Factor (EGF)IBA 10/2013
1	Gefitinib (Iressa)FDA Link 10/2013
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 10/2013
1	Cetuximab (Erbitux)FDA Link 10/2013
1	OligonucleotidesIBA 01/2013
1	Monoclonal AntibodiesIBA 01/2013
1	Toll-Like Receptor 9IBA 12/2010
1	AntigensIBA 07/2010
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2008
1	Vinblastine (Vinblastine Sulfate)FDA Link 07/2007
1	Sirolimus (Rapamycin)FDA Link 07/2007
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 07/2007
1	Therapeutic UsesIBA 07/2007

Therapy/Procedure

14	Therapeutics 01/2023 - 07/2010
2	Precision Medicine 02/2024 - 01/2023
2	Drug Therapy (Chemotherapy) 11/2018 - 07/2010
1	Molecular Targeted Therapy 02/2024
1	Investigational Therapies (Experimental Therapy) 01/2019
1	Ligation 01/2016
1	Induction Chemotherapy 04/2015
1	Radiotherapy 10/2013